Northern Trust’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-80,401
| Closed | -$392K | – | 4413 |
|
|
2025
Q1 | $392K | Sell |
80,401
-1,299
| -2% | -$7.81K | ﹤0.01% | 3668 |
|
|
2024
Q4 | $681K | Buy |
81,700
+4,907
| +6% | +$42.9K | ﹤0.01% | 3539 |
|
|
2024
Q3 | $798K | Sell |
76,793
-3,973
| -5% | -$66K | ﹤0.01% | 3430 |
|
|
2024
Q2 | $1.59M | Sell |
80,766
-296
| -0.4% | -$5.93K | ﹤0.01% | 3026 |
|
|
2024
Q1 | $2.08M | Buy |
81,062
+31,050
| +62% | +$796K | ﹤0.01% | 2940 |
|
|
2023
Q4 | $1.38M | Sell |
50,012
-6,589
| -12% | -$402K | ﹤0.01% | 3176 |
|
|
2023
Q3 | $3.44M | Buy |
56,601
+426
| +0.8% | +$29.9K | ﹤0.01% | 2654 |
|
|
2023
Q2 | $3.7M | Buy |
56,175
+10,037
| +22% | +$734K | ﹤0.01% | 2667 |
|
|
2023
Q1 | $2.93M | Buy |
46,138
+7,099
| +18% | +$811K | ﹤0.01% | 2764 |
|
|
2022
Q4 | $5.4M | Buy |
39,039
+5,003
| +15% | +$705K | ﹤0.01% | 2437 |
|
|
2022
Q3 | $4.31M | Buy |
34,036
+2,374
| +7% | +$269K | ﹤0.01% | 2582 |
|
|
2022
Q2 | $2.62M | Sell |
31,662
-3,450
| -10% | -$268K | ﹤0.01% | 2909 |
|
|
2022
Q1 | $3.41M | Sell |
35,112
-887
| -2% | -$117K | ﹤0.01% | 2807 |
|
|
2021
Q4 | $7.19M | Sell |
35,999
-19,403
| -35% | -$4.58M | ﹤0.01% | 2471 |
|
|
2021
Q3 | $13.7M | Sell |
55,402
-1,371
| -2% | -$392K | ﹤0.01% | 2054 |
|
|
2021
Q2 | $23.5M | Buy |
56,773
+32,376
| +133% | +$12.8M | ﹤0.01% | 1777 |
|
|
2021
Q1 | $9.53M | Buy |
24,397
+194
| +0.8% | +$95.5K | ﹤0.01% | 2328 |
|
|
2020
Q4 | $13.6M | Sell |
24,203
-361
| -1% | -$229K | ﹤0.01% | 2060 |
|
|
2020
Q3 | $17.2M | Sell |
24,564
-240
| -1% | -$187K | ﹤0.01% | 1747 |
|
|
2020
Q2 | $19.6M | Buy |
24,804
+3,531
| +17% | +$2.66M | ﹤0.01% | 1645 |
|
|
2020
Q1 | $12.7M | Buy |
21,273
+1,407
| +7% | +$1.37M | ﹤0.01% | 1725 |
|
|
2019
Q4 | $22.6M | Buy |
19,866
+345
| +2% | +$375K | 0.01% | 1644 |
|
|
2019
Q3 | $23.2M | Sell |
19,521
-1,025
| -5% | -$1.57M | 0.01% | 1578 |
|
|
2019
Q2 | $33.9M | Buy |
20,546
+83
| +0.4% | +$144K | 0.01% | 1303 |
|
|
2019
Q1 | $41.7M | Buy |
20,463
+518
| +3% | +$912K | 0.01% | 1105 |
|
|
2018
Q4 | $25.6M | Buy |
19,945
+180
| +0.9% | +$276K | 0.01% | 1366 |
|
|
2018
Q3 | $37.4M | Buy |
19,765
+1,165
| +6% | +$2.41M | 0.01% | 1273 |
|
|
2018
Q2 | $37.8M | Sell |
18,600
-27,118
| -59% | -$61.8M | 0.01% | 1256 |
|
|
2018
Q1 | $101M | Buy |
45,718
+204
| +0.4% | +$519K | 0.03% | 553 |
|
|
2017
Q4 | $105M | Buy |
45,514
+2,310
| +5% | +$4.69M | 0.03% | 544 |
|
|
2017
Q3 | $76.9M | Buy |
43,204
+3,162
| +8% | +$4.42M | 0.02% | 685 |
|
|
2017
Q2 | $54.5M | Buy |
40,042
+4,180
| +12% | +$5.04M | 0.02% | 864 |
|
|
2017
Q1 | $42.2M | Buy |
35,862
+694
| +2% | +$708K | 0.01% | 1052 |
|
|
2016
Q4 | $28.1M | Buy |
35,168
+3,384
| +11% | +$2.69M | 0.01% | 1343 |
|
|
2016
Q3 | $27.9M | Buy |
31,784
+584
| +2% | +$423K | 0.01% | 1313 |
|
|
2016
Q2 | $17.5M | Buy |
31,200
+19,747
| +172% | +$11.2M | 0.01% | 1624 |
|
|
2016
Q1 | $6.55M | Buy |
11,453
+1,103
| +11% | +$677K | ﹤0.01% | 2249 |
|
|
2015
Q4 | $8.61M | Buy |
10,350
+111
| +1% | +$111K | ﹤0.01% | 2121 |
|
|
2015
Q3 | $11.3M | Sell |
10,239
-9,796
| -49% | -$17.9M | ﹤0.01% | 1905 |
|
|
2015
Q2 | $43.7M | Sell |
20,035
-2,161
| -10% | -$4.4M | 0.01% | 958 |
|
|
2015
Q1 | $34.7M | Buy |
22,196
+3,831
| +21% | +$5.05M | 0.01% | 1148 |
|
|
2014
Q4 | $21.8M | Sell |
18,365
-550
| -3% | -$368K | 0.01% | 1472 |
|
|
2014
Q3 | $8.79M | Buy |
18,915
+11,726
| +163% | +$5.41M | ﹤0.01% | 2124 |
|
|
2014
Q2 | $3.59M | Buy |
7,189
+231
| +3% | +$74.1K | ﹤0.01% | 2745 |
|
|
2014
Q1 | $2.05M | Sell |
6,958
-462
| -6% | -$140K | ﹤0.01% | 3123 |
|
|
2013
Q4 | $2.02M | Buy |
7,420
+4,617
| +165% | +$1.29M | ﹤0.01% | 3146 |
|
|
2013
Q3 | $979K | Buy |
+2,803
| New | +$1.04M | ﹤0.01% | 3334 |
|
Other funds holding BLUE
Northern Trust's BLUE Position: Q2 2025 in Review
Northern Trust sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 80,401 shares — an estimated $392K sold.
Northern Trust first reported a position in BLUE in Q3 2013 and held it in 47 quarters. The position peaked at $105M in Q4 2017. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- Northern Trust reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- Northern Trust sold 80,401 bluebird bio shares in Q2 2025, an estimated $392K.
- Northern Trust first reported a position in bluebird bio in Q3 2013 and held it in 47 quarters.
- Northern Trust's bluebird bio position peaked at $105M in Q4 2017.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on Northern Trust's 13F filing for Q2 2025, filed 13 Aug 2025.